MedTrace Logo

National Longitudinal Cohort of Hematological Diseases- Autoimmune Hemolytic Anemia

NCT07019038 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 9999

Last updated 2025-06-17

No results posted yet for this study

Summary

Hematological diseases are disorders of the blood and hematopoietic organs. The current hematological cohorts are mostly based on single-center or multi-center cases, or cohorts with limited sample size in China. There is a lack of comprehensive and large-scale prospective cohort studies in hematology.

The objectives of this study are to investigate the incidence and risk factors of autoimmune hemolytic anemia (AIHA) and to analyze the treatment effectiveness, patient prognosis and healthcare costs in China.

1. Analyze the demographic and clinical characteristics of patients with AIHA, including sex, age, disease severity, and other relevant factors.
2. Examine disease features of AIHA patients, such as biochemical and hematological indicators
3. Assess treatment patterns and real-world effectiveness in AIHA patients.
4. Evaluate clinical outcomes, including hematologic response, relapse, and mortality
5. Investigate long-term prognosis, including post-discontinuation outcomes and health-related quality of life.

Conditions

  • AIHA - Warm Autoimmune Hemolytic Anemia
  • AIHA - Cold Autoimmune Hemolytic Anemia
  • Autoimmune Hemolytic Anemia Mixed Type

Interventions

OTHER

A combined retrospective and prospective observational follow-up

The NICHE-AIHA will collect basic information, diagnostic and treatment information, as well as health costs information of patients from medical records. The study will use questionnaire to measure the exposure of patients, and prospectively follow-up to collect the prognosis information.

Sponsors & Collaborators

  • Institute of Hematology & Blood Diseases Hospital, China

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-01-01
Primary Completion
2070-12-31
Completion
2070-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07019038 on ClinicalTrials.gov